REZOLUTE, INC.

RZLT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011
Operating Activities
Net Income $-20.3M $-14.9M $-11.4M $-9.7M $-6.7M $-91.2K $-590.2K
Depreciation & Amortization $11.3K $295
Depreciation $1.1M $744.0K $128.9K $7.8K $0
Amortization $7.3K $7.3K $5.3K $3.5K $295 $0
Stock-Based Compensation $6.0M $3.8M $2.8M $1.1M $3.7M $0
Net Cash from Operating Activities $-13.3M $-10.5M $-7.1M $-3.2M $-1.6M $-45.2K $-363.2K
Investing Activities
Capital Expenditures
Business Acquisitions
Net Cash from Investing Activities $-195.4K $185.1K $-2.0K $-414.1K
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities $13.9M $1.4M $52.3K $777.5K
Net Change in Cash
Free Cash Flow
← Newer Page 2 of 2 Older →